Pharmatest Services Revenue and Competitors

Pharmatest Services (Pharmatest) is a preclinical contract research organization offering translational research services for diseases with unmet clinical needs. We offer full-service research solutions for early drug development. Our focus is on preclinical efficacy models in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays to in vivo models. In addition, we provide model and assay development services for our customers. Pharmatest can help you establish the proof-of-efficacy of your cancer drug candidates with clinically predictive cell culture assays, organotypic 3D models, orthotopic animal models, and disseminated cancer models. Our models of skeletal diseases include clinically predictive bone cell culture assays and animal models of osteoporosis and osteoarthritis that can also be used for bone safety testing. Our services have been developed with just one goal in mind – to make your nonclinical drug development faster and more predictive. Our mission is to reduce the amount of drug candidates failing in clinical trials. Outsource your preclinical efficacy testing to Pharmatest and increase significantly the speed of your drug development with reduced costs.